Caplin Steriles bags USFDA approval for Ketorolac tromethamine Ophthalmic Solution
Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin
Point Laboratories Limited, has been granted final
approval by the United States Food and Drug Administration (USFDA) for its Abbreviated
New Drug Application (ANDA) Ketorolac tromethamine Ophthalmic Solution 0.5% (eye
drops).
The product is a generic therapeutic equivalent version of (RLD), ACULAR Ophthalmic Solution of
Allergan Inc.
Ketorolac tromethamine Ophthalmic Solution 0.5% is a nonsteroidal, anti- inflammatory
indicated for the treatment of inflammation following cataract surgery and for the temporary
relief of ocular itching due to seasonal allergic conjunctivitis.
Seasonal allergic conjunctivitis is an allergic reaction that affects the eyes, triggered by airborne allergens such as pollen, mold spores, and pet dander during specific seasons.
According to IQVIA (IMS
Health), Ketorolac tromethamine Ophthalmic Solution 0.5% had US sales of approximately
$36 million for the 12-month period ending December 2023.
Read also: Low BP treatment: Caplin Steriles bags USFDA nod for Norepinephrine Bitartrate Injection
Caplin Point Laboratories Limited is a pharmaceutical company with a end to end business model catering predominantly to emerging markets of Latin America and Africa. The Company has state of the art manufacturing facilities that cater to a complete range of finished dosage forms.
Read also: Caplin Point Labs reappoints Dr C K Gariyali as Independent director
Caplin Steriles Limited, a Subsidiary of Caplin Point Laboratories Limited, is a sterile product manufacturing company that is approved by several regulatory agencies such
as US FDA, EU-GMP, INVIMA and ANVISA. Caplin Steriles Limited, has developed and filed 39
ANDAs in USA on its own and with partners, with 26 approvals so far. The Company is also
working on a portfolio of 40+ simple and complex Injectable and Ophthalmic products, that it
intends to file over the next 4 years. The company also has multiple products filed with several
approvals in non-US markets such as Mexico, Australia, Canada, South Africa etc.
Read also: 
Caplin Steriles gets USFDA nod for Ofloxacin Otic Solution
